DISCLOSEDQuarterly
Duquesne Family Office
Adma Biologics Inc · NASDAQ
2,784,110 sh · $23.3M
Filed 30 Jun 2026SEC 13Fview source
BlackRock
13F filer
$208.4M
18,644,711 sh
Duquesne Family Office
13F filer
$23.3M
2,784,110 sh
Two Sigma Investments
13F filer
$18.9M
2,092,133 sh
Renaissance Technologies
13F filer
$11.4M
1,262,634 sh
Bridgewater Associates
13F filer
$4.3M
472,108 sh
Polen Capital Management
13F filer
$553.8K
30,412 sh
Duquesne Family Office
Adma Biologics Inc · NASDAQ
2,784,110 sh · $23.3M
Two Sigma Investments
Adma Biologics Inc · NASDAQ
2,092,133 sh · $18.9M
Duquesne Family Office
Adma Biologics Inc · NASDAQ
1,545,610 sh · $13.9M
Bridgewater Associates
Adma Biologics Inc · NASDAQ
472,108 sh · $4.3M
Renaissance Technologies
Adma Biologics Inc · NASDAQ
1,262,634 sh · $11.4M
Duquesne Family Office
Adma Biologics Inc · NASDAQ
252,200 sh · $4.6M
Polen Capital Management
Adma Biologics Inc · NASDAQ
30,412 sh · $553.8K
BlackRock
Adma Biologics Inc · NASDAQ
18,644,711 sh · $208.4M